Sterling Pharma Solutions
Duncan Knowles is an experienced professional in supply chain and warehouse management, currently serving as Warehouse Manager at Sterling Pharma Solutions since November 2020. Previously, Duncan held the position of Supply Chain Manager at Recipharm from February 2019 to October 2020. Prior to that, Duncan worked at Coty as a Production Line Manager for Luxury Fragrances, where responsibilities included managing production standards and overseeing team redundancies, as well as leading teams in various supply chain functions. Duncan's career at Procter & Gamble spanned from 2007 to 2016, with roles including Warehouse Continuous Improvement Leader and New Product Delivery Leader. Duncan holds a Master of Engineering degree in Chemical Engineering from The University of Edinburgh, earned between 2002 and 2007.
This person is not in any teams
This person is not in any offices
Sterling Pharma Solutions
1 followers
Sterling Pharma Solutions has over 50 years' experience serving the global pharmaceutical industry. Our facilities are located in Cramlington and Newcastle Biosphere, UK; Deeside, Wales; Cork, Ireland, as well as North Carolina and Wisconsin in the US. Our state-of-the-art facilities, proprietary technologies and experienced people are among the best in the industry. We have a proven track record in the supply of chemistry and analytical services across the entire product lifecycle, from grams to tonnes, from pre-clinical to commercial supply. Our world-class safety and quality standards are globally recognised and demonstrated through successful MHRA and FDA inspections and CIA Gold Awards for Safety the last three consecutive years. We pride ourselves on our customer focus and service approach, offering flexible, tailored solutions to our customers. In addition, our North Carolina and Newcastle Biosphere facilities offer expert chemistry solutions for small volume batches or products in the early stages of clinical trials. Our Deeside, Wales facility provide bioconjugation development services and specialised in antibody drug conjugation (ADC) research and development. Find out more: www.sterlingpharmasolutions.com/sterling-facilities